The Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) heart failure Validation Study: Diagnosis and prognosis

This publication has 30 references indexed in Scilit:

• Trends in Heart Failure Incidence and Survival in a Community-Based Population
  JAMA, 2004
• Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
  The Lancet, 2003
• Diuretic Versus α-Blocker as First-Step Antihypertensive Therapy
  Hypertension, 2003
• Health Outcomes Associated With Various Antihypertensive Therapies Used as First-Line Agents
  JAMA, 2003
• Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
  JAMA, 2002
• Long-Term Trends in the Incidence of and Survival with Heart Failure
  New England Journal of Medicine, 2002
• ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure)
  Circulation, 2001
• Prevention of Heart Failure by Antihypertensive Drug Treatment in Older Persons With Isolated Systolic Hypertension
  JAMA, 1997
• Evolving trends in the epidemiologic factors of heart failure: Rationale for preventive strategies and comprehensive disease management
  American Heart Journal, 1997
• Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
  American Journal of Hypertension, 1996